Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- THE CLEVELAND CLINIC FOUND
- Publication Date
- 2008-02-06
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
field of invention
[0001] The invention relates to a method for tissue regeneration of ischemic cardiomyopathy, in particular to a method for treating ischemic cardiomyopathy after myocardial infarction for a long time (that is, multiple weeks). Background of the invention
[0002] Acute myocardial infarction (MI) remains the leading cause of morbidity and death in Western societies. Although recent therapeutic advances have been directed primarily at restoring perfusion to arteries associated with early infarcts, a "ceiling" of benefit exists, Topol, E.J. Lancet 357, 1905-1914 (2001). Patients with acute myocardial infarction (MI) essentially eventually develop congestive heart failure, mostly due to left ventricular (LV) remodeling, a process that involves the heart muscle becoming thinned, dilated, reduced in function, and eventually dead (CHF). Robbins, M.A. & O'Connell, J.B., pp.3-13 (Lippincott-Raven, Philadelphia, 1998). Pfeffer, J.M., Peffer, M.A., Fletcher, P.J. &...